Back to Authors

Eliason, L

A5004900351 | I4210099842

Mayo Clinic

GlaxoSmithKline, Bengaluru (India), 17*Upper Providence (USA), 17†Zug (Switzerland)

Citations 1

P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?

HemaSphere | April 6, 2022 | Volume: 6 | Issue: No issue available | Pages: 18-18

10.1097/01.hs9.0000829624.40467.0d